N,N-二甲基-2-苯基丁烷-1-胺 | 33132-91-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N,N-二甲基-2-苯基丁烷-1-胺
• 英文名称: N,N-Dimethyl-2-phenyl-butylamin
• 英文别名: 2-Phenyl-N.N-dimethylbutylamin；Dimethyl(2-phenylbutyl)amin；Phenethylamine, N,N-dimethyl-beta-ethyl-；N,N-dimethyl-2-phenylbutan-1-amine
• CAS: 33132-91-1
• 化学式: C₁₂H₁₉N
• 分子量: 177.29
• InChiKey: UMAKZNFESLTKKX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2921499090

反应信息

• 作为反应物：
  描述：

  N,N-二甲基-2-苯基丁烷-1-胺 在 双氧水 作用下， 生成 N,N-Dimethyl(2-phenylbutyl)amin-N-oxid
  参考文献：
  名称：

  Lardicci,L. et al., Organometallics in Chemical Synthesis, 1972, vol. 1, p. 447 - 454

  摘要：

  DOI：
• 作为产物：
  描述：

  2-苯基丁酸 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 生成 N,N-二甲基-2-苯基丁烷-1-胺
  参考文献：
  名称：

  Lardicci,L. et al., Organometallics in Chemical Synthesis, 1972, vol. 1, p. 447 - 454

  摘要：

  DOI：

文献信息

• Synthesis of 5-Alkylidene-6-(dimethylamino)methyl-1,3-cyclohexadienes from α-Substituted Benzyldimethylammoniomethylides
  作者：Yoshio Machida、Naohiro Shirai、Yoshiro Sato

  DOI：10.1055/s-1991-26393

  日期：——

  2-Substituted 5-alkylidene-6-(dimethylamino)methyl-1,3-cyclohexadienes (E)-4 and (Z)-4 were prepared by the reaction of α,4-disubstituted dimethyl[(trimethylsilyl)methyl]benzylammonium iodides 2 with cesium fluoride. Their E-isomers were stable at room temperature and could be used in the Diels-Alder reaction. Some related reactions are also described.

  通过铯氟化物与α,4-二取代的二甲基[(三甲基硅基)甲基]苄基铵碘化物的反应，制备了2-取代的5-烷叉基-6-(二甲基氨基)甲基-1,3-环己二烯（E）-4和（Z）-4。其E-异构体在室温下稳定，并可用于Diels-Alder反应。同时，还描述了一些相关的反应。
• Photochemical addition of tertiary amines to electrophilic cyclopropanes via single electron transfer
  作者：Hideo Tomioka、Hiroshi Miyagawa

  DOI：10.1039/c39880001183

  日期：——

  Irradiation of arylcyclopropanes bearing at least one electron-withdrawing group with a tertiary amine in acetonitrile resulted in the formation of the regioselective addition product of the amine along with the reduction product.

  在乙腈中用叔胺辐照带有至少一个吸电子基团的芳基环丙烷会导致胺的区域选择性加成产物与还原产物一起形成。
• MULTI-RING COMPOUNDS AND USES THEREOF
  申请人：Ohler Norman E.

  公开号：US20100249111A1

  公开（公告）日：2010-09-30

  Chemical agents, such as derivatives of hydroxy benzene moieties, and similar heterocyclic ring structures, including salts thereof, that act as anti-cancer and anti-tumor agents, especially where such agents modulate the activity of enzymes and structural polypeptides present in cells, such as cancer cells, or where the agents modulate levels of gene expression in cellular systems, including cancer cells, are disclosed, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents.

  本发明涉及化学制剂，例如羟基苯基衍生物及类似的杂环环结构，包括其盐，其作为抗癌和抗肿瘤制剂，特别是这些制剂调节细胞中的酶和结构多肽的活性，例如癌细胞，或这些制剂调节细胞系统中的基因表达水平，包括癌细胞等。本发明还涉及制备这些制剂的方法，以及包含这些制剂作为活性成分的制药组合物和使用这些制剂作为治疗剂的方法。
• [EN] COMBINATION THERAPIES WITH SETD2 INHIBITORS<br/>[FR] POLYTHÉRAPIES AVEC DES INHIBITEURS DE SETD2
  申请人：EPIZYME INC

  公开号：WO2022261243A1

  公开（公告）日：2022-12-15

  The present disclosure provides SETD2 protein inhibitors, and methods, uses, compositions, and kits for treating diseases, disorders, or conditions in a subject with a SETD2 protein inhibitor and a Second Therapeutic Agent, wherein the Second Therapeutic Agent comprises one or more BTK inhibitors, one or more anti-CD20 monoclonal antibodies, one or more alkylating agents, one or more topoisomerase II inhibitors, one or more vinca alkaloids, one or more platinum-based drugs, one or more nucleoside anticancer agents, one or more PI3K inhibitors, one or more CDK4/6 inhibitors, one or more CARM1 inhibitors, one or more inhibitors of enzymes of DNA damage repair, one or more SYK inhibitors, or one or more MEK inhibitors, or a combination thereof.

  本公开提供SETD2蛋白抑制剂，以及使用SETD2蛋白抑制剂和第二治疗剂治疗受试者的方法、用途、组合物和试剂盒，其中第二治疗剂包括一种或多种BTK抑制剂、一种或多种抗CD20单克隆抗体、一种或多种烷基化剂、一种或多种拓扑异构酶II抑制剂、一种或多种长春烷类生物碱、一种或多种铂类药物、一种或多种核苷类抗癌药物、一种或多种PI3K抑制剂、一种或多种CDK4/6抑制剂、一种或多种CARM1抑制剂、一种或多种DNA损伤修复酶抑制剂、一种或多种SYK抑制剂或一种或多种MEK抑制剂，或其组合。
• 8-OXODIHYDROPURINE DERIVATIVE
  申请人：Dainippon Sumitomo Pharma Co., Ltd.

  公开号：EP2476682A1

  公开（公告）日：2012-07-18

  The present invention provides a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof (wherein W represents a hydrogen atom, a halogen atom, or the others; A represents an alkyl group optionally substituted by aryl group or the others, an aryl group, or the others; and one of X and Y represents a di-substituted alkylaminocarbonyl group, or the others, and the other represents a hydrogen atom, an alkyl group, an alkylcarbonyl group, or the others); a medicament or a pharmaceutical composition for treatment or prophylaxis of FAAH-related diseases such as depression, anxiety disorder or pains, comprising the compound or the like as an active ingredient; a use of the compound or the like; and a method for treatment or prophylaxis using the compound or the like.

  本发明提供了由式（1）代表的化合物或其药学上可接受的盐（其中W代表氢原子、卤素原子或其它原子；A代表任选被芳基或其它基团取代的烷基、芳基或其它基团；X和Y中的一个代表二取代的烷基氨基羰基或其它基团，另一个代表氢原子、烷基、烷基羰基或其它基团）；用于治疗或预防 FAAH 相关疾病（如抑郁症、焦虑症或疼痛）的药物或药物组合物，其中包含该化合物或类似物作为活性成分；该化合物或类似物的用途；以及使用该化合物或类似物进行治疗或预防的方法。